Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

doi:10.1053/j.gastro.2014.03.051

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Gastroenterology - 1 Jul 2014

Hézode Christophe, Fontaine Helene, Dorival Celine, Zoulim Fabien, Larrey Dominique, Canva Valerie, De Ledinghen Victor, Poynard Thierry, Samuel Didier, Bourliere Marc, Alric Laurent, Raabe Jean-Jacques, Zarski Jean-Pierre, Marcellin Patrick, Riachi Ghassan, Bernard Pierre-Henri, Loustaud-Ratti Veronique, Chazouilleres Olivier, Abergel Armand, Guyader Dominique, Metivier Sophie, Tran Albert, Di Martino Vincent, Causse Xavier, Dao Thong, Lucidarme Damien, Portal Isabelle, Cacoub Patrice, Gournay Jerome, Grando-Lemaire Veronique, Hillon Patrick, Attali Pierre, Fontanges Thierry, Rosa Isabelle, Petrov-Sanchez Ventzislava, Barthe Yoann, Pawlotsky Jean-Michel, Pol Stanislas, Carrat Fabrice, Bronowicki Jean-Pierre

Abstract excerpt

BACKGROUND & AIMS: We investigated the effectiveness of the protease inhibitors peginterferon and ribavirin in treatment-experienced patients with hepatitis C virus (HCV) genotype 1 infection and cirrhosis. METHODS: In the Compassionate Use of Protease Inhibitors in Viral C Cirrhosis study, 511 patients with HCV genotype 1 infection and compensated cirrhosis who did not respond to a prior course of peginterferon...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Comorbidity

Share to Interferon-alpha

Share to Liver Cirrhosis

Share to Oligopeptides

Share to Polyethylene Glycols

Share to Proline

Share to Ribavirin

Share to Treatment Failure

Source

Open in PubMed

Identifiers

PMID: 24704719
DOI: 10.1053/j.gastro.2014.03.051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.PMID 24704719Read ↗

Effectiveness and safety of first-generation protease inhibitors in real-world patients with hepatitis C virus genotype 1 infection in Brazil: a multicenter study.Semantic proximity Read ↗

Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.Semantic proximity Read ↗

Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?Semantic proximity Read ↗

Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.Semantic proximity Read ↗

Efficacy and tolerability of telaprevir for chronic hepatitis virus C genotype 1 infection: a meta-analysis.Semantic proximity Read ↗

A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.Semantic proximity Read ↗

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.Semantic proximity Read ↗

Telaprevir for retreatment of HCV infection.Semantic proximity Read ↗

Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir.Semantic proximity Read ↗

UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.Semantic proximity Read ↗

Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.